Why Is NIH Always In the Middle of Nefarious Situations?

Why does the NIH always seem to be in the middle of nefarious situations involving vaccines?

Decades ago, the NIH became the deep cover for bioweapon development after the Patriot Act was passed. The CIA was squeamish about being prosecuted for violating the Geneva Convention, so they put bioweapons “research” under Anthony Fauci.

During COVID, the four scientists who went along with the natural origin theory, and who also authored the infamous paper entitled The Proximal Origin of SARS-CoV-2 collectively received $50 million in grants from – you guessed it – NIH.

Now, we are learning about an under-the-table deal that occurred in the waning days of the Biden administration, and once again, the NIH was right in the middle of it. It seems the agency awarded a large $28 million grant to a biomedical company called Vaccine Company, Inc., a company that is quite mysterious, actually.

Nothing to see here.

About the Company

The company has a next-to-nothing public profile. There’s no website, and an extremely sparse LinkedIn profile – both a bit strange if you are actually trying to do business.  The Washington Free Beacon reports that the company has registration filings in three states: Maryland, California, and Massachusetts. For the Bethesda, Maryland location, the company lists a P.O. Box as its address, a clear violation of receipt of any NIH grant, as grantees typically must have a physical address. The LinkedIn profile lists San Francisco as the company headquarters. CEO Gregory C. Thayer has a similarly sparse LinkedIn profile. Prior to this role, his profile states he was an attorney at Flehr, Hohbach, Test, Albritton & Herbert, described as a firm that has been in business over 50 years, specializing in intellectual property law in pharmaceuticals and biotechnology. But they don’t have a LinkedIn profile or website either. 

Quite strange. 

From 1995 to 2001, Thayer was CFO of doubleTwist, a company that makes “delicious music and podcast apps.”  Hmmm…from music to mRNA vaccines…that is quite the leap. This company was founded in Norway, is currently headquartered in Austin, Texas, and has raised over $10 million with investors like Microsoft and Michael Ovitz, the former president of Disney. After 2001, Thayer’s profile goes blank. It states he is the current CEO of Vaccine Company, Inc. but there is no starting year to show how long he has been in the job.

The Vaccine Company (TVC)  is backed by venture capital money, and lots of it, having raised its Series C round for $20 million from InvestBio, Inc., a New York-based biotechnology sector investment firm. The investment was so that TVC could start a Phase III clinical trial for its PR1 peptide vaccine targeting acute myelogenous leukemia (AML). While the Free Beacon reports that TVC was founded in 2022, there is another report stating that the company was founded in 2003 specifically to commercialize the PR1 vaccine; the technology originated at Houston’s University of Texas MD Anderson Cancer Center and was likely licensed to TVC through a technology transfer commercial license agreement, typically done in cases to transfer innovations from academia to companies to bring the product to market. The 2003 founder is listed as Ron Garren, M.D., but you guessed it, no trace of this person either. TVC’s current CEO is listed in its California filings as former Pfizer executive Susan Silbermann, who led Pfizer’s global COVID-19 task force.

Which Begs the Question…

Interestingly, despite reports of a successful Phase III clinical trial, the AML vaccine was never FDA approved. The Free Beacon also states that public records show TVC’s involvement in at least two COVID mRNA vaccine clinical trials in 2023, according to Synapse, a global drug intelligence database. But again, no vaccine came to fruition.

This begs the question: why would the NIH give nearly $30 million to a company that has never developed an FDA-approved vaccine, and one that appears to have no appreciable work in 20 years? In fact, the grant is the only federal award TVC has ever received.